The FDA's rejections of Replimune and Capricor therapies show how instability threatens biotech innovation, CEOs say.
An unnamed source clarified that Sandra Retzky has not been fired from the FDA, but it remains unclear where she was ...
Under the Trump administration, the Department of Health and Human Services and the Food and Drug Administration have been ...
Current and former FDA staff said the level of involvement of political officials in nitty-gritty regulatory matters is ...
Heading into the final quarter of a year that has seen dramatic upheaval at the FDA—from the exodus of numerous senior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback